ROYCE & ASSOCIATES LP - VIVOS THERAPEUTICS INC ownership

VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 11 filers reported holding VIVOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of VIVOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$1,723,000
-25.4%
348,0000.0%0.01%
-25.0%
Q1 2021$2,311,000
+30.3%
348,000
+16.0%
0.02%
+6.7%
Q4 2020$1,773,000300,0000.02%
Other shareholders
VIVOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 162,500$804,0000.46%
BARD ASSOCIATES INC 215,500$1,067,0000.35%
Millrace Asset Group, Inc. 93,993$465,0000.24%
Archon Capital Management LLC 215,000$1,064,0000.12%
Penn Capital Management Company, LLC 223,403$1,106,0000.11%
GRIFFIN ASSET MANAGEMENT, INC. 49,500$245,0000.03%
K2 PRINCIPAL FUND, L.P. 64,746$320,0000.03%
Walleye Capital LLC 150,000$743,0000.02%
WMS Partners, LLC 16,667$153,0000.02%
Avalon Investment & Advisory 189,739$939,0000.02%
View complete list of VIVOS THERAPEUTICS INC shareholders